Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Methods. 2021 Oct 7;198:76–87. doi: 10.1016/j.ymeth.2021.10.002

Table 2:

Routes with the highest variations among BRCA, COAD, and STAD cohorts

ID Route (p1 - Signaling route, p2 - Effector Route) BRCA COAD STAD

PS ARS PS ARS PS ARS
9 Adipocytokine signaling pathway(p1) LEP, LEPR, PPARA, RXRA, RXRB, RXRG 0.99 −0.97 0.1 −0.38 0.1 −0.35
176 IL-17 signaling pathway(p2) FOS, FOSB, JUN, JUND, FOSL1, IL6 0.89 −0.84 0.14 0.22 0.73 −0.65
460 Toll-like receptor signaling pathway(p2) FOS, JUN, IL12A, IL12B, TNF, IL1B, IL6 0.81 −0.41 0.16 0 0.66 −0.34
110 ErbB signaling pathway(p1) EGF, TGFA, AREG, EGFR, ERBB2, STAT5A, STAT5B 0.74 −0.73 0.17 −0.21 0.1 0.06
424 Thyroid hormone signaling pathway(p2) THRA, MYH6, MYH7, ATP2A2, ATP2A1, ATP2A3, PLN 0.78 −0.47 0.23 −0.32 0.14 −0.23
434 Tight junction(p2) YBX3, CDK4, SYMPK, CCND1 0.08 0.25 0.72 0.91 0.17 0.46
299 PPAR signaling pathway(p2) PPARG, RXRA, RXRB, RXRG, SCD5, SCD, FADS2, ME1, ME3 0.69 −0.3 0 0.22 0.11 0.04
400 Th17 cell differentiation(p2) MAPK14, MAPK11, MAPK13, MAPK12, IRF4 0.05 −0.11 0.66 −0.57 0.48 −0.44
432 Tight junction(p2) JUN, CD1A, CD1B, CD1C, CD1D, CD1E 0.59 −0.54 0.1 0.07 0.63 −0.6
472 Wnt signaling pathway(p2) TCF7, TCF7L1, TCF7L2, TCF4, LEF1, FOSL1, JUN, MYC, MMP7, PPARD, WISP1, CCND1, CCND2, CCND3, Cell cycle 0.12 −0.06 0.41 0.25 0.13 0.05